Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 7/7/2020
SIETES contiene 93061 citas

 1 a 20 de 60 siguiente >>
Presentar resultados
Seleccionar todas
2.Tiene citas relacionadas Cita con resumen
Vandrey R, Raber JC, Douglass B, Miller C, Bonn-Miller MO. Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA 2015;313:2491-3. [Ref.ID 99311]
3. Cita con resumen
Young K. NY attorney general: store-brand supplements rarely contain the herbs shown on the label. Physician's First Watch 2015:4 de febrero. [Ref.ID 98755]
4. Cita con resumen
Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med 2013;11:222. [Ref.ID 96274]
5.Enlace a cita original
Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol 2013;69:295-307. [Ref.ID 95150]
6. Cita con resumen
Elsharkawy AM, McPherson S, Masson S, Burt AD, Dawson RT, Hudson M. Cholestasis secondary to anabolic steroid use in young men. BMJ 2012;344:47-9. [Ref.ID 92357]
8. Cita con resumen
Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS, Green DM, Sklar CA, Robison LL, Leisenring WM. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2010;340:34. [Ref.ID 87668]
9. Cita con resumen
Vannacci A, Lapi F, Baronti R, Gallo E, Gori L, Mugelli A, Firenzuoli F. Too much effectiveness from a herbal drug. Br J Clin Pharmacol 2009;67:473-4. [Ref.ID 85823]
10. Cita con resumen
Kao SL, Chan CL, Lim CCT, Dalan R, Gardner D, Pratt E, Lee M, Lee KO. An unusual outbreak of hypoglycemia. N Engl J Med 2009;360:734-6. [Ref.ID 85252]
11.Tiene citas relacionadas Cita con resumen
Kashyap AS, Anand KP, Kashyap S. Artesunate for malaria. N Engl J Med 2008;359:314. [Ref.ID 83552]
12.Tiene citas relacionadas
Schwartz LB. Heparin comes clean. N Engl J Med 2008;358:2505-9. [Ref.ID 83135]
13.Tiene citas relacionadas
Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, Al-Hakim A, Bailey GS, Fraser B, Roy S, Rogers-Cotrone T, Buhse L, Whary M, Fox J, Nasr M, Dal Pan GJ, Shriver Z, Langer RS, Venkataraman G, Austen KF, Woodcock J, Sasisekharan R. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008;358:2457-67. [Ref.ID 83131]
14.Tiene citas relacionadas Cita con resumen
Avorn J. Coagulation and adulteration - Building on science and policy lessons from 1905. N Engl J Med 2008;358:2429-31. [Ref.ID 83129]
15. Cita con resumen
Anónimo. Combating counterfeit drugs. Lancet 2008;371:1551. [Ref.ID 82867]
16.Enlace a cita original Cita con resumen
Anónimo. Herbal products are found to contain prescription drugs. BMJ 2007;335:1232. [Ref.ID 81789]
Jack A. Bitter pills. BMJ 2007;335:1120-1. [Ref.ID 81666]
18. Cita con resumen
Anónimo. China's ex-drug head executed as another is sentenced to death. Scrip 2007;3276:17. [Ref.ID 80581]
19. Cita con resumen
Cienski J. Polish drug factory closed after treatment mix up. Lancet 2006;368:2116. [Ref.ID 78673]
20.Tiene citas relacionadas Cita con resumen
Avorn J. Dangerous deception - hiding the evidence of adverse drug effects. N Engl J Med 2006;355:2169-71. [Ref.ID 78556]
Seleccionar todas
 1 a 20 de 60 siguiente >>